Completed PHASE4 INTERVENTIONAL 2-arm NCT03929146

Liposomal Bupivacaine Versus Interscalene Nerve Block

Randomized Trial Comparing Interscalene Nerve Block to Liposomal Bupivacaine For Pain Management Following Reverse Total Shoulder Arthroplasty (RTSA)

Sponsor: University of Cincinnati

Conditions Pain, Postoperative

Interventions Exparel Interscalene Nerve Block

Updated 8 times since 2019 Last updated: May 8, 2023 Started: Feb 5, 2019 Primary completion: Nov 1, 2022 Completion: Nov 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Pain, Postoperative, this trial is completed. The trial is conducted by University of Cincinnati and has accumulated 8 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jun 2023 — Jul 2024 [monthly]

Completed PHASE4

Status: Recruiting → Completed
Mar 2022 — Jun 2023 [monthly]

Recruiting PHASE4
May 2021 — Mar 2022 [monthly]

Recruiting PHASE4

▶ Show 3 earlier versions

Jan 2021 — May 2021 [monthly]

Recruiting PHASE4
Feb 2020 — Jan 2021 [monthly]

Recruiting PHASE4
May 2019 — Feb 2020 [monthly]

Recruiting PHASE4

First recorded

Feb 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Cincinnati

Data source: University of Cincinnati

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cincinnati, United States